During the past decade, Dongzhimen Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dongzhimen Hospital" #1 sponsor was "Dongzhimen Hospital, Beijing" with 22 trials, followed by "Beijing University of Chinese Medicine" with 3 trials sponsored, "China Academy of Chinese Medical Sciences" with 2 trials sponsored, "Beijing Municipal Science & Technology Commission" with 1 trials sponsored and "Chen Xiangmei" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dongzhimen Hospital" #1 collaborator was "Beijing Chao Yang Hospital" with 2 trials as a collaborator, "Beijing Emergency Medical Center" with 2 trials as a collaborator, "Beijing Tiantan Hospital" with 2 trials as a collaborator, "Dongzhimen Hospital, Beijing" with 2 trials as a collaborator and "Guang'anmen Hospital of China Academy of Chinese Medical Sciences" with 2 trials as a collaborator. Other collaborators include 113 different institutions and companies that were collaborators in the rest 108 trials.

According to Clinical.Site data, the most researched conditions in "Dongzhimen Hospital" are "Acute Ischemic Stroke" (4 trials), "Ischemic Stroke" (3 trials), "Stroke" (3 trials), "Vascular Dementia" (3 trials) and "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Dongzhimen Hospital" in a lesser frequency.

Most popular intervention types in "Dongzhimen Hospital" are "Drug" (23 trials), "Other" (8 trials), "Behavioral" (2 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Placebos" (3 trials), "Standard care" (3 trials), "Xingnaojing injection" (3 trials) and "1612 capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dongzhimen Hospital" are 31 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Dongzhimen Hospital". 1 are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Dongzhimen Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dongzhimen Hospital, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 5 trials that are defined as “Not Applicable".